FDA approved the first Home COVID-19 Test Kit
- A Single US$2.15-Million Injection to Block 90% of Cancer Cell Formation
- WIV: Prevention of New Disease X and Investigation of the Origin of COVID-19
- Why Botulinum Toxin Reigns as One of the Deadliest Poisons?
- FDA Approves Pfizer’s One-Time Gene Therapy for Hemophilia B: $3.5 Million per Dose
- Aspirin: Study Finds Greater Benefits for These Colorectal Cancer Patients
- Cancer Can Occur Without Genetic Mutations?
FDA approved the first Home COVID-19 Test Kit
FDA approved the first Home COVID-19 Test Kit. On December 9, local time, the U.S. Food and Drug Administration (FDA) approved the emergency use authorization for the first batch of non-prescription COVID-19 test kits for home use.
The U.S. Food and Drug Administration said at a press conference on the 9th that LabCorp’s home collection kit product Pixel for the detection of COVID-19 virus allows all people over 18 to purchase it. Testers can send nasal swab samples after collecting them at home Send to the relevant organization of LabCorp for testing.
After the test is completed, the positive or invalid results will be reported back to the tester via the phone or the healthcare provider. If the result is negative, the tester will be notified via email or official website.
The U.S. Food and Drug Administration said that the kit can help people understand their health at any time and determine whether and when they need to self-isolate. After discussing with healthcare providers, its test results can also help testers make healthcare decisions.
LabCorp also emphasized that the new home test kit cannot replace the doctor’s visit, and it is recommended that people still focus on the doctor’s diagnosis.
Gutentor Simple Text
Gutentor Simple Text
